Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter

Purpose: The aim was to determine the combined value of serological lipid metabolism and an orbital MRI quantitative parameter in predicting the effectiveness of glucocorticoid (GC) therapy in patients with thyroid eye disease (TED). Methods: This study retrospectively enrolled 46 patients with ac...

Full description

Bibliographic Details
Main Authors: Haitao Zhang, Hao Hu, Yueyue Wang, Xinjie Duan, Lu Chen, Jiang Zhou, Wen Chen, Weizhong Zhang, Xiaoquan Xu, Huanhuan Chen
Format: Article
Language:English
Published: Bioscientifica 2024-01-01
Series:European Thyroid Journal
Subjects:
Online Access:https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0109.xml
_version_ 1827349677808287744
author Haitao Zhang
Hao Hu
Yueyue Wang
Xinjie Duan
Lu Chen
Jiang Zhou
Wen Chen
Weizhong Zhang
Xiaoquan Xu
Huanhuan Chen
author_facet Haitao Zhang
Hao Hu
Yueyue Wang
Xinjie Duan
Lu Chen
Jiang Zhou
Wen Chen
Weizhong Zhang
Xiaoquan Xu
Huanhuan Chen
author_sort Haitao Zhang
collection DOAJ
description Purpose: The aim was to determine the combined value of serological lipid metabolism and an orbital MRI quantitative parameter in predicting the effectiveness of glucocorticoid (GC) therapy in patients with thyroid eye disease (TED). Methods: This study retrospectively enrolled 46 patients with active and moderate-to-severe TED (GC-effective group, n = 29; GC-ineffective group, n = 17). Serological lipid metabolism, the orbital MRI-based minimum signal intensity ratio of extraocular muscles (EOM-SIRmin), as well as other clinical parameters before GC therapy were collected and compared between the two groups. Multivariate logistic regression and receiver operating characteristic curve analysis were adopted to identify independent predictable variables and assess their predictive performances. Results: Compared to the GC-ineffective group, the GC-effective group showed lower serum total cholesterol levels (P = 0.006), lower serum low-density lipoprotein cholesterol levels (P = 0.019), higher EOM-SIRmin values (P = 0.005), and shorter disease durations (P = 0.017). Serum total cholesterol and EOM-SIRmin were found to be independent predictors of GC-effective TED through multivariate analysis (odds ratios = 0.253 and 2.036 per 0.1 units, respectively) (both P < 0.05). The integration of serum total cholesterol ≤4.8 mmol/L and EOM-SIRmin ≥ 1.12 had a better predictive efficacy (area under the curve, 0.834) than EOM-SIRmin alone, with a sensitivity of 75.9% and a specificity of 82.4% (P = 0.031). Conclusion: Serological lipid metabolism, combined with an orbital MRI-derived parameter, was a useful marker for predicting the effectiveness of GCs in patients with active and moderate-to-severe TED.
first_indexed 2024-03-08T00:45:26Z
format Article
id doaj.art-b7d9176ee53441b0a24f4c11210dbfbf
institution Directory Open Access Journal
issn 2235-0802
language English
last_indexed 2024-03-08T00:45:26Z
publishDate 2024-01-01
publisher Bioscientifica
record_format Article
series European Thyroid Journal
spelling doaj.art-b7d9176ee53441b0a24f4c11210dbfbf2024-02-15T12:36:56ZengBioscientificaEuropean Thyroid Journal2235-08022024-01-01131110https://doi.org/10.1530/ETJ-23-0109Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameterHaitao Zhang0Hao Hu1Yueyue Wang2Xinjie Duan3Lu Chen4Jiang Zhou5Wen Chen6Weizhong Zhang7Xiaoquan Xu8Huanhuan Chen9Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Ophthalmology, The Friendship Hospital of Ili Kazakh Autonomous Prefecture Ili & Jiangsu Joint Institute of Health, Ili, China; Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaPurpose: The aim was to determine the combined value of serological lipid metabolism and an orbital MRI quantitative parameter in predicting the effectiveness of glucocorticoid (GC) therapy in patients with thyroid eye disease (TED). Methods: This study retrospectively enrolled 46 patients with active and moderate-to-severe TED (GC-effective group, n = 29; GC-ineffective group, n = 17). Serological lipid metabolism, the orbital MRI-based minimum signal intensity ratio of extraocular muscles (EOM-SIRmin), as well as other clinical parameters before GC therapy were collected and compared between the two groups. Multivariate logistic regression and receiver operating characteristic curve analysis were adopted to identify independent predictable variables and assess their predictive performances. Results: Compared to the GC-ineffective group, the GC-effective group showed lower serum total cholesterol levels (P = 0.006), lower serum low-density lipoprotein cholesterol levels (P = 0.019), higher EOM-SIRmin values (P = 0.005), and shorter disease durations (P = 0.017). Serum total cholesterol and EOM-SIRmin were found to be independent predictors of GC-effective TED through multivariate analysis (odds ratios = 0.253 and 2.036 per 0.1 units, respectively) (both P < 0.05). The integration of serum total cholesterol ≤4.8 mmol/L and EOM-SIRmin ≥ 1.12 had a better predictive efficacy (area under the curve, 0.834) than EOM-SIRmin alone, with a sensitivity of 75.9% and a specificity of 82.4% (P = 0.031). Conclusion: Serological lipid metabolism, combined with an orbital MRI-derived parameter, was a useful marker for predicting the effectiveness of GCs in patients with active and moderate-to-severe TED.https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0109.xmlthyroid eye diseaseglucocorticoid therapyeffectivenessserological lipid metabolismmri
spellingShingle Haitao Zhang
Hao Hu
Yueyue Wang
Xinjie Duan
Lu Chen
Jiang Zhou
Wen Chen
Weizhong Zhang
Xiaoquan Xu
Huanhuan Chen
Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter
European Thyroid Journal
thyroid eye disease
glucocorticoid therapy
effectiveness
serological lipid metabolism
mri
title Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter
title_full Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter
title_fullStr Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter
title_full_unstemmed Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter
title_short Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter
title_sort predicting glucocorticoid effectiveness in thyroid eye disease combined value from serological lipid metabolism and an orbital mri parameter
topic thyroid eye disease
glucocorticoid therapy
effectiveness
serological lipid metabolism
mri
url https://etj.bioscientifica.com/view/journals/etj/13/1/ETJ-23-0109.xml
work_keys_str_mv AT haitaozhang predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT haohu predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT yueyuewang predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT xinjieduan predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT luchen predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT jiangzhou predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT wenchen predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT weizhongzhang predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT xiaoquanxu predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter
AT huanhuanchen predictingglucocorticoideffectivenessinthyroideyediseasecombinedvaluefromserologicallipidmetabolismandanorbitalmriparameter